Most bacteriophages rapidly infect and kill bacteria and, therefore, qualify as the next generation therapeutics for rapidly emerging drug-resistant bacteria such as Mycobacterium tuberculosis. We have previously characterized the mycobacteriophage D29-generated endolysin, Lysin A, for its activity against mycobacteria. Here, we present a detailed characterization of the lysozyme domain (LD) of D29 Lysin A that hydrolyzes peptidoglycan of both grampositive and gram-negative bacteria with high potency. By characterizing an exhaustive LD protein variant library, we have identified critical residues important for LD activity and stability. We further complement our in vitro experiments with detailed in silico investigations. We present LD as a potent candidate for developing phage-based broad-spectrum therapeutics.
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, poses a continuous threat to mankind. With the rapid occurrence of drug-resistant Mtb, it has now become extremely important to search for more potent drugs and alternate therapeutics [1] . Mycobacteriophage can be considered as a suitable alternative to antibiotics because of its natural ability to infect and kill mycobacteria. The release of the assembled virion particles present in the bacterial cytoplasm is ensured by the concerted and timely action of three mycobacteriophage-encoded proteins-Holin, Lysin A, and Lysin B that, respectively, disrupt cytoplasmic membrane, cell wall peptidoglycan, and outer mycolic acid layer [2] [3] [4] [5] . These molecules are, therefore, considered as potential therapeutics to treat mycobacterial as well as other bacterial infections [6] [7] [8] [9] .
Lysins or endolysins can be engineered and delivered using bacteriophages to make them more effective against bacterial infections [10] [11] [12] . Taking advantage of their modular nature, different domains of endolysins have been fused to prepare chimeric lysins that have shown better lytic capabilities than the parent endolysin [13, 14] . Recently, a new class of lysins, termed 'artilysin', has been prepared where a cationic antimicrobial peptide is added to the endolysin to achieve disruption of the outer membrane of gramnegative bacteria, thereby allowing the endolysin to readily access the peptidoglycan [15] . Indeed, artilysins have proven to be extremely potent against multidrugresistant and persister strains of Acinetobacter baumannii and Pseudomonas aeruginosa [16] [17] [18] . It has been Abbreviations NAG, N-acetylglucosamine; NAM, N-acetylmuramic acid.
shown that a combination therapy of antibiotic and lysin against the methicillin-resistant Staphylococcus aureus is very effective when compared with the treatment with antibiotic alone [19] . Endolysins have also been used for other purposes such as pathogen detection, vaccine development, and the preparation of an inducible Escherichia coli autolysis system [20, 21] .
We have earlier shown that mycobacteriophage D29 Lysin A has three domains. Two domains present at the N terminus have catalytic activity, whereas the third domain present at the C terminus binds specifically to the mycobacterial cell wall [3] . Here, we provide an indepth view of the central lysozyme domain (LD) of Lysin A, which has the peptidoglycan hydrolase activity against gram-positive Micrococcus lysodeikticus and gram-negative E. coli [3] . By screening an exhaustive library of LD variants using biophysical and biochemical methods, and carrying out detailed computational analyses, we were able to map the active site of the enzyme. Our work thus helps in understanding the structure-function relationship in the LD of mycobacteriophage endolysin, which can be developed as a potent broad-spectrum antibacterial.
Materials and methods
Details pertaining to the reagents, bacterial strains, media and growth conditions, construction of clones, site-directed mutagenesis, and purification of proteins are provided in Doc. S1. List of clones generated and the oligos used to generate these clones are presented in Tables S1 and S2 , respectively.
Biophysical analysis using circular dichroism (CD) spectroscopy and differential scanning calorimetry (DSC) Secondary structure analysis using CD was performed as described previously [22] , and is detailed in Doc. S1. Molar ellipticity values at 222 nm were recorded and used to calculate fraction unfolded as described elsewhere [23] . The unfolding transition of LD WT and its variants was also monitored using Differential scanning calorimetry on a Microcal VP-DSC (GE Healthcare, Chicago, IL, USA) as detailed in Doc. S1. Microcal-VPDSC analysis software was used to estimate the thermodynamic parameter, DH (calorimetry enthalpy).
In vitro and in vivo enzyme activity assays
In vitro activity assays of LD WT and its variants were performed by zymography and EnzChek Lysozyme Assay kit (Invitrogen, Waltham, MA, USA) as detailed in Doc. S1. Zymography experiment was carried out as described [3] with some modifications. Briefly, M. lysodeikticus cells were immobilized in an SDS/polyacrylamide gel, on which proteins boiled in SDS gel loading dye were electrophoresed. Following electrophoresis, the gel was washed and stained with methylene blue in KOH. Enzyme activity was measured by quantifying the cleared zone density by IMAGEJ software (v1.48; National Institutes of Health, Bethesda, MD, USA) and normalizing it with respect to the protein band density obtained from a separately run Coomassie-stained SDS/PAGE gel using IMAGEJ. Fluorescence-based activity assays were performed using EnzChek Lysozyme Assay as per manufacturer's instructions. In vivo activity of the proteins was elucidated by chloroform assay as detailed in Doc. S1.
Protein modeling, validation, and molecular dynamics simulations
The LD domain, from 153rd to 380th residues with respect to the full-length Lysin A, was modeled on I-TASSER [24] and the resulting model was validated and refined as detailed in the Doc. S1. MD simulation was carried using GROMACS 4.5 package (Science for Life Laboratory, Stockholm, Sweden) with Gromos96 54a7 force field [25, 26] as detailed in Doc. S1.
Ligand-binding site prediction, protein, and ligand preparation, and induced fit docking Preparation of LD model and ligands for docking, ligandbinding site prediction, and induced fit docking studies were carried out as detailed in Doc. S1. Briefly, the ligandbinding site in LD model was mapped using SiteMap module (v3.4; Schr€ odinger, New York, NY, USA). While the LD model was prepared for docking using Protein Preparation Wizard (Maestro 10.2; Schr€ odinger), ligands were prepared using LigPrep module (v3.4; Schr€ odinger). Induced Fit Docking protocol (Schr€ odinger) was used in this study as described previously [27] .
Molecular dynamics-based binding free energy calculation
Binding free energy calculations were carried out as detailed in Doc. S1. Briefly, binding free energy was calculated using MM/PBSA approach using GMXPBSA 2.1 tool available in GROMACS [28] . Trajectories of wild-type and mutant complexes were assessed over 20 ns of MD simulation along with topology of protein and ligand. A total of 100 frames were taken from each MD trajectory for the calculation.
Results
Serendipitous development of a novel strategy to identify active site residues in lysozyme domain of Lysin A D29 mycobacteriophage Lysin A harbors two catalytic domains and one cell wall-binding domain, and functions as a peptidoglycan hydrolase [3] . We have previously shown that the LD present in the middle of the protein (153rd to 380th amino acid with respect to fulllength Lysin A of D29 mycobacteriophage) can hydrolyze bacterial peptidoglycan in vitro [3] . Since, a BLAST search using the LD protein sequence as query against the PDB database available at NCBI revealed no homologous sequence (data not shown), we decided to identify critical residues required for protein's function by carrying out mutagenesis and activity assays.
To develop an in vivo enzyme assay, we first attempted to clone the LD-coding DNA sequence along with OmpA secretory signal sequence tag (sec-LD). This was essential since the substrate for LD, that is, peptidoglycan, is physically separated from the cell cytoplasm (site of protein production) by a cell membrane, and a sec-tag will allow the protein to overcome this barrier.
The sec-LD cloning was performed in pET21b expression vector under T7 promoter, in E. coli XL1-Blue. However, our several attempts of cloning yielded only mutated versions of sec-LD carrying frameshift, deletions, or point mutations; one such mutated construct was used in an earlier study [3] . On the other hand, it was possible to clone LD without a sec-tag in pET21b [3] . The complete sequence of the sec-LD as expected after cloning is depicted in Fig. S1 . We imagined that the spurious expression of sec-LD in E. coli XL1-Blue (that is generally used only for gene cloning) caused stress that resulted in mutations in the gene followed by the selection of nontoxic or inactive variants. It immediately indicates that a mutation in sec-LD gene, which makes the enzyme inactive, should also make the gene 'clonable'. We, therefore, chose the 'natural selection' method to identify residues that are critical for LD protein's activity.
To ascertain if spurious expression of sec-LD gene causes mutations, we replaced the ORF's second codon (+ 4, + 5, and + 6 nucleotides) with a translation stop codon, TGA. Expectedly, we were able to clone such construct (labeled as sec-LD-Stop) in pET21b under T7 promoter ( Fig. 1) without any other mutations (data not shown). We thus proceeded with this construct and first tried to identify the longest LD gene sequence that can be cloned with sec-tag without the incorporation of any undesirable mutations. To achieve this, we initially introduced a stop codon TAG in sec-LD-Stop gene at defined positions (601st, 646th, 676th, and 694th) through site-directed mutagenesis. After confirming the introduction of these stop codons by DNA sequencing, we attempted to 'repair' the generated ORFs by replacing the TGA stop codon at + 4 nucleotides with GGA and looked for the 'repaired' constructs. We envisaged that the smallest ORF that spuriously expresses in the cell but does not cause stress will not accumulate any mutations other than what was introduced through in vitro site-directed mutagenesis. Three colonies for each 'repaired' construct were sequenced and screened for the appearance of any undesirable mutation. We noticed that while the constructs sec-LD-675 and sec-LD-693 accumulated mutations (either frameshift or point mutations) upon reversing the + 4-nucleotide stop codon, the ORFs sec-LD-600 and sec-LD-645 remain unaffected (data not shown). Thus, our data suggest that 10 residues coded by the nucleotides present between 649th and 678th positions (Fig. S1 ) in the gene are somehow required for the activity of LD.
Identification of critical amino acids required for D29 Lysin A lysozyme domain activity
The cloning of LD with sec-tag indicated a 10-aa segment to be involved in LD's activity. To further Fig. 1 . Schematic of the sec-LD cloned in pET21b. P T7 and lacO represent T7 promoter and lac operator, respectively, that are present in the vector. Ribosome-binding site (RBS) is depicted along with the sequence. NdeI site provides start codon ATG followed by OmpA sec-tag; complete sec sequence is not shown. NheI is present at the junction of the sec-tag and LD gene. 'H' represents the hexa-histidine tag, added by the vector. Schematic of the changes made to introduce a stop codon after the translation initiation site into the sec-LD gene is shown. Only necessary region is depicted. The changed nucleotides are shown in lower case letters.
recognize the specific amino acid(s) in the 10-aa segment identified above (Fig. S1 ), we performed Alascanning mutagenesis of the region. Ala-scanning mutagenesis was first carried out in the LD gene devoid of sec-tag through site-directed mutagenesis, and the mutations were confirmed by DNA sequencing. Subsequently, the mutated genes were cloned with sec-tag in pET21b. We discovered that out of the 10 residues, substitution of R198 to Ala resulted in a 'clonable' gene. In other words, sec-LD gene harboring only the R198A codon substitution did not accumulate any other mutations. However, this was not the case with remaining nine residues, and substitution of them with Ala resulted in sequences with undesirable mutations. Conceivably, these mutations would have resulted in an inactive molecule.
To examine the effect of Ala substitution on LD's activity and stability, we proceeded with expressing all the Ala-substituted proteins without sec-tag in E. coli BL21(DE3), purifying them on Ni-nitrilotriacetic acid chromatography, and carrying out in vitro activity assays using zymography and fluorescence. Interestingly, only the R198A variant of LD (LD R198A ) was found to be inactive in vitro as judged by both zymography and fluorescence-based assay using the EnzChek lysozyme assay ( Fig , although demonstrated lesser activity than the wild-type protein (LD WT ) in zymography, showed significant activity in the fluorescence-based assay ( Fig. 2A,B; Fig. S2 ). The data thus indicate that LD R198A is an inactive enzyme. Furthermore, LD R198A protein was also found to be inactive in our in vivo activity assays that were carried out by expressing the sec-tag-less proteins in E. coli BL21(DE3) and adding chloroform into the culture medium. Addition of chloroform resulted in a sharp decline in the optical density at 600 nm (OD 600 ) of the E. coli culture expressing LD WT ( Fig. 2C; Fig. S3 ). However, OD 600 reduction in the case of LD R198A was comparable to pET21b-induced control and was insignificant ( Fig. 2C; Fig. S3 ). The other Ala-substituted variants showed activity close to LD WT ( Fig. 2C;  Fig. S3 , suggesting that they are enzymatically active. Thus, we conclude that only R198A substitution in LD severely impairs its activity both in vivo and in vitro, even though the far-UV CD spectra obtained for both LD WT and LD R198A showed similar profiles indicating a largely folded a-helical protein, the thermal denaturation analysis showed drastic differences (Fig. S4) .
Interestingly, the thermal denaturation profiles of all the Ala-substituted proteins, as measured by CD, showed lower T m values as compared to the LD WT , indicating lower thermal stabilities of the variants ( Table 1 ). The unfolding of LD WT was observed to be a two-state process with a single-step transition from a and its Ala-substituted variants. The zone of clearance in each case was analyzed with IMAGEJ after normalizing the data with respect to the loaded protein band intensity on a Coomassie-stained gel. The WT activity was considered as 100%. The %activity of all the variants was calculated with respect to the WT and plotted. (B) Fluorescence-based activity assays were carried out using fluorescent-labeled Micrococcus lysodeikticus cells as available in EnzChek Lysozyme assay kit (Invitrogen). The activity of each protein was measured as an increase in fluorescence at 530 nm and recorded after 60 min as relative fluorescence units (RFU), and normalized with respect to the WT. BSA was used as negative control. (C) Chloroform assay was performed to assess in vivo activity of WT and its variants. IPTG was added to induce protein expression, and after 30 min of induction, chloroform was added to a final concentration of 2% v/v into the culture medium. The growth was monitored at 600 nm every 2 min for a period of 10 min after addition of chloroform. OD 600 before chloroform addition was considered as 100% and the reduction in OD 600 after 10 min was estimated and plotted as %reduction. pET21b empty vector served as negative control. Here, R198A variant shows activity equivalent to the empty vector. In all the panels, the experiments were carried out at least thrice and the data presented are an average with standard deviation (P value analysis: *< 0.05; **< 0.01; ***< 0.001; ****< 0.0001; n.s not significant, P > 0.05, when activity of the LD WT was compared to the Ala-substituted variants). In all the panels, only the substitution in LD is mentioned on the x-axis. We have shown that during Ala-scanning mutagenesis of the 10-aa segment, mutation of R198 to Ala resulted in a sequence with zero undesirable mutations. However, the replacement of codons for the remaining nine residues with Ala codon yielded sequences with undesirable mutations and we isolated 16 such unique missense mutants where it was possible to reverse Ala codon to the original one without having any other mutation in the gene (Table S3) ; here, the G121D variant was observed twice (Table S3 ) and, therefore, only one of the two proteins was studied further. We hypothesized that these mutated sequences could be obtained because they produced inactive enzyme and, therefore, did not cause toxicity to the cells. To study these proteins in greater detail, we proceeded with their cloning without sec-tag, expression, and protein purification. Since four mutants out of the 16 showed a drastic reduction in the solubility (Table S3) , we examined in detail the 12 remaining proteins. Our zymography and chloroform assays suggest that all the proteins are inactive both in vitro and in vivo ( Fig. 3;  Fig. S5 ). Furthermore, both far-UV CD and DSC data demonstrate decreased stability of all the LD variants, performed to compare the activity of the LD WT (WT) and its variants. The zone of clearance was analyzed with IMAGEJ after normalizing the data with respect to the loaded protein band intensity on a Coomassie-stained gel. The WT activity was considered as 100%. The %activity of each variant was calculated with respect to the WT and plotted (**P < 0.01). (B) Chloroform assay was performed to assess in vivo activity of WT and its variants. IPTG was added to induce protein expression, and after 30 min of induction, chloroform was added to a final concentration of 2% v/v into the culture medium. The growth was monitored at 600 nm every 2 min for a period of 10 min. OD 600 before chloroform addition was considered as 100% and the reduction in OD 600 after 10 min was estimated and plotted as %reduction. pET21b empty vector served as negative control. In both panels, the experiments were carried out at least thrice and the data presented are an average with standard deviation (*P < 0.05 when activity of the LD WT was compared to each single-amino acid variant). In both the panels, only the substitution in LD is mentioned on the x-axis.
as judged by lowering of T m and DH compared to LD WT (Table S4) . Taken together, our data indicate that the naturally occurring mutations in LD gene make the protein inactive and unstable. It further suggests that these residues belong to the enzyme active site.
Computational analysis of the LD protein to identify the active site
The LD mutation data identified several residues critical for enzyme activity. To map the active site, we next performed a detailed computational analysis of the protein. The 16 unique mutations in which the Ala substitution could be reversed are presented in Fig. 4A . It is noticeable that most mutations are localized in a region of the protein spanning from K112 to G121. To explore the conservation pattern and evolutionary significance of these residues, we carried out a database search for the LD-like proteins, performed a multiple sequence alignment of the homologous sequences, and generated weblogo. Interestingly, most of the residues that underwent substitution were also found to be conserved (Fig. 4B) ; nearly 100% retention of the amino acids present in the K112 to G121 segment is immediately apparent. Additionally, other missense mutants that were isolated viz. Y92, N189, G190, and R198, were also found to be conserved. Evidently, highly conserved residues undergo mutation to negatively affect LD's activity and stability. This is essential for the cell to survive, even though, conceivably, only miniscule amount of protein will be produced from the spurious expression of the gene.
We next generated a 3D model of LD to map the active site. Since the crystal structure of LD is not available and a BLAST search against PDB database using LD sequence as query did not yield any homolog (data not shown), we generated the 3D model of LD on I-TASSER [24] . The generated model was further refined as detailed in Doc. S1, and subjected to molecular dynamic simulation for 100 ns that finally yielded a stable structure. In total, eight helices were observed in the LD WT 3D model -a1 (E31-A36), a2 (Y31-Q57), a3 (P63-E76), a4 (D93-T96), a5 (K122-W131), a6 (L154-E168), a7 (L181-R187), and a8 (L195-A205); refer Fig. 4 for amino acid sequence. The far-UV CD data obtained for LD WT (Fig. S4 ) allowed us to further validate the in silico wild-type (WT) protein model. The secondary structure content of the computational model as estimated using DSSP [29] was found to be 36.6% helix, 0% b-sheet, and 63.2% random coil that largely concurred with the values obtained from LD WT CD spectrum (37% helix, 11% b-sheet, and 53% random coil) analyzed with CAPITO-CD tool [30] , barring some b-sheet content deviation.
Next, the substrate-binding pocket was identified using the SiteMap module (Schr€ odinger) and was further docked with the three substrates viz. NAG-NAM, NAM-NAG, and NAM-NAG-NAM on the LD model using Induced Fit Docking module (Schr€ odinger). The SiteMap module (Schr€ odinger) predicted three potential substrate-binding sites in the LD model (Table 2) . Site_1 showed the highest Site score and Dscore (a score around 1.0 is considered significant), and thus was the best candidate for the active site ( Table 2 ). All the ligands preferentially docked Site_1 of the model (Table 2 ; Fig. 5, Fig. S6 ) and yielded docking score corresponding to À9.68, À10.09, and À10.55 for NAG-NAM, NAM-NAG, and NAM-NAG-NAM, respectively, whereas the docking of ligands with other two sites gave lesser scores as compared to the Site_1 (Table S5 ). The docking data further allow us to suggest that Site_1 is the LD active site.
Our Ala-scanning mutagenesis experiment has shown that R198 is a critical residue that is required for both activity and stability of LD. Subsequently, the Ala-mutation reversal experiments also demonstrated 12 residues in LD that are critical for the activity as judged by the data presented above. A detailed investigation of the predicted active site (Site_1) demonstrated that six out of the 12 experimentally identified residues viz. Y92, K112, G113, M118, T120, and N189 are located in the active site of the modeled LD (Table 2 , Fig. 5 ). In addition, three residues viz. S115, W163, R198 are available in close proximity of the substrate-binding pocket (Fig. 5) . Taken together, our in silico data largely concur with our activity assays carried out with the LD variants. The data thus strongly suggest that the predicted Site_1 in the LD model is indeed the active site of the molecule.
In silico mutation of the active site provides deeper insights into the LD model
The LD mutagenesis experiments performed above revealed several critical residues, substitution of which led to the lowering of activity and/or stability. To examine the impact of such mutations on the protein's activity and stability, we selected R198 and replaced it with Ala in the LD model. Here, R198 was chosen for two reasons. Firstly, the LD variant R198A was found to be inactive in both in vivo and in vitro experiments, and this substitution also lowered the stability of the protein significantly. Secondly, since R198 is located away from the K112-G121 segment, where most of the mutations were observed (Fig. 4) , it was of interest to examine the molecular perturbations that were a result of R198A substitution in LD leading to enzyme inactivity. We initiated our in silico experiments by first replacing R198 with Ala in the LD model and then subjecting it to a 100 ns MD simulations. Data thus obtained for R198A model was compared with that of WT. The Root Mean Square Deviation values obtained for C a of R198A model showed a gradual increase with time and did not attain stability during the entire simulation period (Fig. S7A) . On the other hand, the WT model attained stability at around 20 ns and remained stable throughout the simulation (Fig. S7A) . Furthermore, the Solvent Accessible Surface Area (SASA) value was found to be lower for R198A variant as compared to the WT (Fig. S7B) . These data suggest that there is an overall change in LD structure upon replacement of R198 with Ala, which corroborates well with the change in the stability observed in vitro. The substrate-binding pocket analysis offered interesting insights (Fig. 6) . In the WT model, R198 interacts with its neighboring residues viz. Q72, H75, N194, and Y202; two other residues N194 and D197 also interact with H75. These residues together hold a small helix (a7) and the adjacent loop region in a unique (Fig. 6A) . Moreover, the side chain of R198 also provides a conformational rigidity that restricts the movement of helix (a7) and the adjoining loop. Upon replacing R198 with Ala, these constraints are lost resulting in helix and loop region attaining higher degree of freedom, thus allowing them to protrude into the binding cavity (Fig. 6B) . Additionally, in R198A model, residues I188, N189, and G191 that are present in the loop region (adjacent to a7) form stable interactions with T94, R95, T120, and H75 of the substrate-binding cavity, further stabilizing the altered conformation (Fig. 6B) . These structural rearrangements in R198A model lead to a collapse of the binding cavity and, in process, also reduce SASA (Fig. S7B ). The WT model further suggests that the interaction of R198 with H75 holds the helix (a3) in the binding cavity and allows it to have four helical turns. This conformation, however, is lost in R198A model, which results in the loss of a single helical turn made up of four residues from 74 to 77 exiting the substrate-binding cavity (Fig. 6 ), leading to further destabilization.
In the R198A model generated above, none of the substrates docked successfully (data not shown) due to the disruption of the active site (Fig. 6) . This supports the loss of activity in LD R198A both in vitro and in vivo. Nevertheless, in order to understand the impact of R198A substitution on the substrate-binding ability of LD, we replaced R198 with Ala in the substrate-docked model of wild-type and further simulated the docked complexes of both WT and R198A for 20 ns. The binding free energy, DG bind (kJÁmol À1 ), of the NAM-NAG-NAM ligand for WT and R198A variant was estimated to be À185.5 AE 3.0 and À107.8 AE 4.7 kJÁmol À1 , respectively (Table S6) . These results clearly indicate that in the LD model, even in the event that the substrate-binding cavity was to remain intact after R198A substitution, the mutation reduces the ligand-protein interaction efficiency. Here, although only one residue R198 has been examined in greater detail, our data obtained from in vitro and in silico experiments nevertheless help us in understanding the underlying structural rearrangements that render the LD protein inactive due to various mutations.
Discussion
Phage-encoded endolysins are the molecules of interest as alternative to antibiotics. These proteins are naturally produced and cause bacterial host lysis thus allowing the release of newly assembled virions. LD domain of D29 Lysin A has been predicted to possess N-acetyl-muramidase activity belonging to glycoside hydrolase (GH19) family of proteins [6] . Although GH19 class of proteins are present in phages infecting gram-positive bacteria such as Mycobacterium, Gordonia, and Corynebacterium [31] , recent reports of characterization of the enzyme from phages infecting gram-negative bacteria have provided greater insights [32, 33] . A comprehensive study of these proteins will certainly help in developing them as novel antibacterial therapeutics. Here, we have presented a detailed analysis of the LD of D29 mycobacteriophage Lysin A, which is capable of hydrolyzing peptidoglycan of both gram-positive and gram-negative bacteria. It thus offers itself as a broad spectrum antibacterial molecule for therapeutic purposes.
We had earlier noticed that it was difficult to clone LD-coding DNA with a secretory signal sequence tag. The cloning attempts always yielded clones with mutations. In the present study, we show that these mutations are most likely caused by the spurious expression of the gene in E. coli XL1-Blue (which is meant primarily for cloning). We believe that the spurious expression of the gene results in a stress that causes mutations followed by the selection of mutated gene. This is not uncommon-in an earlier study, plasmid instability was observed during cloning of hepatitis C virus gene (HCV) that gave rise to a defective gene product due to frameshift mutations or mismatch resulting in the stop codon [34] . In the present work, use of the 'natural selection' method to determine the active site of the LD enzyme is a serendipitous discovery. It remains to be seen if similar strategy can be applied to the dissection of other less studied proteins.
We have carried out a detailed computational, biophysical, and biochemical examination of the LD wildtype and its variants and show that our analyses from various methods complement each other. We are able to decipher the significance of several residues in the overall structural integrity and function of the LD molecule. Ala-scanning mutagenesis of a specific 10-aa segment in LD allowed us to identify several critical residues that are important in protein's activity. Upon closer investigation, we discovered that the evolutionarily conserved residues were preferentially mutated. One of the critical residues, R198, was examined in more detail since this residue is located away from the active site (Fig. S6) , and yet its substitution with Ala makes the protein inactive. Moreover, our computational data show that R198, although does not directly interact with the ligand, plays a crucial role in the building of the active site. The in silico analysis of the LD model allowed us to decipher the role of several residues in protein structure and function.
Glutamic acid residue is considered to be important for the activity of the GH19 proteins [35] , although the catalytic motifs of OBPgp279 and PVP-SE1gp146 are devoid of a Glu [32] . However, in our experiments, we were unable to isolate any glutamic acid residue mutant. This suggests that the D29 LD molecule is somewhat different from the known GH19 family of proteins; nevertheless, a few similarities are apparent. GH19 proteins are known to be largely a-helical proteins [35] . A recent structural study of SNP1S endolysin also revealed that the protein is largely a-helical with Glu49 and Glu58 forming a catalytic dyad [33] . We notice that the D29 LD molecule also shows a largely a-helical conformation. Additionally, the residues that affect the catalytic activity of the SNP1S protein viz. Thr130, Phe166, and Asn187, are also found to be either identical (Thr120, Asn189) or similar (Trp163) to D29 LD since these amino acid variants could readily be isolated in our study (Fig. 4) . Although the data pertaining to the configuration of the active site and the residues involved therein were obtained from a computational model, we believe that it will help in comprehending the structurefunction relationship in the protein, since the model was subjected to molecular dynamics simulations and was further validated by several in vitro experiments.
An understanding of the active site of an enzyme helps in its engineering to obtain a molecule with higher activity. Our work provides important insights into the structural and functional aspects of LD, which will not only assist in the construction of a more stable LD with higher activity but will also facilitate in the development of LD as a novel therapeutic against both gram-positive and gram-negative bacteria. We further wish to add that our work sheds light on bacterial adaptation to a toxic protein by resorting to mutations in the gene when the cells are exposed to it, even if it is produced in a miniscule amount due to spurious expression. We are tempted to postulate that our work may also find its relevance in understanding drug tolerance in bacteria, although experimental data in this regard is presently unavailable.
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